AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glymid-M Tablet

Prescription Icon
Prescription Required

Marketer

Midas Healthcare Ltd

Salt Composition

Gliclazide (80mg) + Metformin (500mg)

Overview Glymid-M Tablet

Diabetam-Duo, a dual-action antidiabetic medication, manages type 2 diabetes in adults. This combined formulation regulates blood glucose. Always take Diabetam-Duo with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may adjust based on your blood sugar response. Continue taking this medicine as prescribed, even if feeling well; discontinuation without medical guidance risks elevated blood sugar, potentially leading to kidney complications, vision loss, neuropathy, and limb problems. Diabetam-Duo is part of a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Common side effects include hypoglycemia (low blood sugar), characterized by sweating, dizziness, headache, and tremors; constipation; and vomiting. Regular meals and readily available glucose sources (e.g., sugary snacks, fruit juice) are crucial to manage hypoglycemia. Alcohol consumption should be limited due to its hypoglycemic risk. Other possible side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur. Diabetam-Duo is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe liver or kidney disease. Inform your doctor of any heart condition history before starting treatment. Pregnant or breastfeeding individuals should seek medical counsel before use. Regular blood glucose monitoring and periodic blood tests (blood cell counts, liver function) are recommended.

Uses of Glymid-M Tablet

Adult-onset diabetes

Major Benefits of Glymid-M Tablet:

Consume this medication precisely as directed by your physician, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Glymid-M Tablet with a meal.

Common Side effects of Glymid-M Tablet:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Dizziness
  • Diarrhea
  • Upper respiratory tract infection
  • Nausea
  • Flatulence
  • Constipation

How to use Glymid-M Tablet:

Consume this medication precisely as directed by your physician, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Glymid-M Tablets should be administered with a meal.

How Glymid-M Tablet works:

Glymid-M tablets contain gliclazide and metformin, two medications used to manage blood sugar levels.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Alcohol and Glymid-M Tablets should not be taken together.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Glymid-M tablets during pregnancy poses a confirmed risk to the fetus. Therefore, it's contraindicated. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Always seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Glymid-M tablets while breastfeeding is likely inadvisable. Available human data indicates a potential for the medication to transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by excessively high or low blood sugar levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Glymid-M Tablets, potentially requiring dosage modification. Consult your physician for guidance. Glymid-M Tablets are contraindicated in patients with severe kidney disease. Regular monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glymid-M tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. A reduced starting dose is usually advised for those with mild to moderate liver disease; Glymid-M tablets are contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Glymid-M Tablet :

Should you forget a Glymid-M Tablet dose, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glymid-M Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glymid-M Tablet

Glymid-M tablets combine gliclazide and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. Glymid-M is not suitable for type 1 diabetes.
Glymid-M Tablet may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Glymid-M Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice for emergencies.
Glymid-M Tablets can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare side effect is preventable by avoiding use in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. Should these symptoms occur, discontinue Glymid-M immediately and seek medical attention.
Prolonged Glymid-M Tablet use can lead to vitamin B12 deficiency by interfering with its stomach absorption. This deficiency, if left untreated, may cause anemia, nerve damage (manifested as tingling, numbness in extremities, weakness), urinary issues, cognitive changes, and ataxia. To mitigate this risk, supplemental vitamin B12 intake at least annually is recommended by some researchers.
Glymid-M Tablets are contraindicated in patients with known allergies to any ingredient or excipient. They should also be avoided in those with moderate to severe kidney disease or metabolic acidosis, including diabetic ketoacidosis.
Combining Glymid-M tablets and alcohol is unsafe. Alcohol can worsen low blood sugar and raise the risk of lactic acidosis.
Glymid-M Tablets combine gliclazide and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood sugar control when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. Glymid-M is unsuitable for type 1 diabetes.
Glymid-M Tablet may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infection. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Glymid-M Tablets can cause low blood sugar (hypoglycemia), resulting in symptoms like nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, and shakiness or anxiety. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Glymid-M Tablets can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare side effect is preventable by avoiding use in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Glymid-M and seek immediate medical attention.
Prolonged Glymid-M Tablet use can lead to vitamin B12 deficiency by impairing its absorption in the stomach. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, supplemental vitamin B12 intake at least annually is recommended by some researchers.
Glymid-M Tablets are contraindicated in patients with known allergies to any ingredient or excipient. They should also be avoided in those with moderate to severe kidney disease or metabolic acidosis, including diabetic ketoacidosis.
Combining Glymid-M tablets and alcohol is unsafe. This combination risks dangerously low blood sugar and raises the likelihood of lactic acidosis.
Glymid-M Tablet
45
MRP 55
18% off